Latest News about NASDAQ:TNXP
Recent news which mentions NASDAQ:TNXP
From News Direct
Tickers
TNXP
From InvestorPlace
Tonix Pharmaceuticals Awarded potential 34 million dollar Contract with U.S. Department of Defence
July 19, 2024
Tags
NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals receives positive feedback from FDA on Tonmya™ for fibromyalgia management
July 18, 2024
Tickers
TNXP
Tags
NASDAQ:TNXP
From News Direct
Tags
NASDAQ:TNXP
From News Direct
Tickers
TNXP
From InvestorPlace
Tickers
TNXP
From InvestorPlace
Tonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defense funded trial
February 28, 2024
Tags
NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals' Fibromyalgia Trial Shows Promising Results in Webinar Presentation
February 28, 2024
Tags
NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals announces key topline data from 2nd Phase 3 Clinical Trial of TNX-102 SL
January 02, 2024
Tags
NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals shared details of IND clearance for Phase 2 trial of TNX-2900
December 12, 2023
Tags
NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals' CEO reveals next-generation COVID vaccine technology chosen for key program
November 20, 2023
Tags
NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals finish Phase 3 trial of TNX-102 SL for management of Fibromyalgia
November 20, 2023
Tags
NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals releases positive results from Proof-Of-Concept Study on TNX-102 SL
September 19, 2023
Tags
NASDAQ:TNXP
From News Direct
Tags
NASDAQ:TNXP
From News Direct
Tags
NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals fibromyalgia study published in American College of Rheumatology
June 28, 2023
Tags
NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals shares breakthrough of TNX-601 ER study on patients with depression
May 31, 2023
Tags
NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals TNX-1500 monoclonal antibody published in American Journal of Transplantation
April 24, 2023
Tags
NASDAQ:TNXP
From News Direct
Tags
NASDAQ:TNXP
From News Direct
Tonix Pharmaceuticals discusses exclusive license of potential monoclonal antibodies
February 02, 2023
Tags
NASDAQ:TNXP
From News Direct
Tonix CEO Calls for New Class of Covid-19 Pre-Exposure and Therapeutic Antibodies for High-Risk Populations
January 24, 2023
Tickers
TNXP
Tags
NASDAQ:TNXP
From News Direct
Why Is Tonix Pharmaceuticals (TNXP) Stock Up 40% Today?
December 12, 2022
Tickers
TNXP
From InvestorPlace
Tonix Pharmaceuticals (TNXP) Stock Surges 15% on Patent News
August 01, 2022
Tickers
TNXP
From InvestorPlace
Why Is Tonix Pharmaceuticals (TNXP) Stock Up 30% Today?
June 01, 2022
Tickers
TNXP
From InvestorPlace
Tickers
TNXP
From Best Stocks
Tonix Pharmaceuticals Stock Belongs in the Biotech Dustbin
March 14, 2022
Tickers
TNXP
From InvestorPlace
Tickers
TNXP
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.